SpringWorks Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference

NEXT STORY
Prelude Therapeutics to Participate at the 4th Annual Evercore ISI HealthCONx Conference
PREV STORY
Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iTeos Therapeutics Announces Pricing of Initial Public Offering

author_avatar
NASDAQ Market News

Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs

author_avatar
NASDAQ Market News

Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board

author_avatar
NASDAQ Market News